Annals of hepatologySep 5, 2026

Role of CD38 in Liver Disease: How It Works, Links to Illness, and Treatment Possibilities

Longevity & Aging Weekly Brief ↗PubMed ↗DOI ↗

Updated Sep 6, 2026

Abstract

CD38 is a multifunctional enzyme that plays a significant role in liver health and disease.

CD38 is expressed on various cell types in the liver and is involved in regulating calcium signaling and NAD+ metabolism.
Increased activity of CD38 is associated with oxidative stress, inflammation, and impaired tissue repair in the liver.
CD38 may promote cellular aging through its influence on NAD+ and calcium levels.
The enzyme is implicated in liver injury, chronic liver diseases, and the development of liver cancer.
CD38 signaling contributes to liver fibrosis and complications in end-stage liver disease and transplantation.
Inhibiting CD38 has been shown to preserve NAD+ levels and aid in tissue recovery and disease progression mitigation.

Simplified

CD38 is a highly conserved multifunctional enzyme that regulates intracellular calcium signaling and NAD⁺ metabolism. Although extensively studied in cancer and autoimmune diseases, growing evidence points to a critical role for CD38 in both normal and diseased liver physiology. In hepatic tissue, CD38 is expressed on multiple cell types. Aberrant CD38 activity contributes to increased oxidative stress, inflammation, and diminished tissue repair. Recent studies suggest that CD38 may also promote cellular senescence partly through its regulation of intracellular NAD⁺ and calcium. This review examines the role of CD38 in maintaining hepatic homeostasis and explores its involvement in liver injury, chronic liver diseases, and carcinogenesis. We also highlight the contribution of CD38-mediated signaling to hepatic fibrogenesis and end-stage liver failure as well as its potential role in liver transplantation, particularly post-transplant related conditions including ischemic injury and acute cellular rejection. Given its impact on multiple intracellular processes, CD38 has emerged as a promising therapeutic target. New findings describe how CD38 inhibition preserves NAD⁺ levels, supports tissue recovery, and mitigates disease progression in the liver. Finally, we outline new frontiers for CD38 in liver biology and the advancement of CD38-targeted therapeutic strategies.

Full Text

Full text is available at the source.

View Full Text ↗

Role of CD38 in Liver Disease: How It Works, Links to Illness, and Treatment Possibilities

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the longevity & aging brief